Elevance Health Inc. (ANTM) — Financial statements
Income statement, balance sheet, and cash flow for Elevance Health Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 199,125↑12.5% | 177,011↑27.7% | 138,639↑13.8% | 121,867↑16.9% | 104,213 | |
| Cost of Revenue | 21,178↑7.2% | 19,750 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 177,947↑13.2% | 157,261↑13.4% | 138,639↑13.8% | 121,867↑16.9% | 104,213 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 13,364 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00 | 0.00↓100.0% | 15,914↓8.8% | 17,450↑30.6% | 13,364 | |
| Other Expenses | 20,984↑4.8% | 20,025↑113.7% | -145,821↓10.2% | -132,295↓257.3% | 84,116 | |
| Operating Expenses | 20,984↑4.8% | 20,025↑115.4% | -129,907↓13.1% | -114,845↓217.8% | 97,480 | |
| Total Costs & Expenses | 42,162↑6.0% | 39,775↓69.6% | 130,714↑13.0% | 115,629↑17.7% | 98,228 | |
| Operating Results | ||||||
| Operating Income | 156,963↑14.4% | 137,236↑1471.6% | 8,732↑24.4% | 7,022↑4.3% | 6,731 | |
| Depreciation & Amortization | 1,546 | 0.00↓100.0% | 1,302↑12.8% | 1,154↑1.9% | 1,133 | |
| EBITDA | 9,658↓93.0% | 137,236↑1267.7% | 10,034↓48.1% | 19,344↑146.0% | 7,864 | |
| EBIT | 8,112↓10.7% | 9,089↑4.2% | 8,723↓52.0% | 18,190↑170.2% | 6,731 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1,402↓18.3% | -1,185↓48.5% | -798↓1.8% | -784↓5.1% | -746 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1,402↑18.3% | 1,185↑48.5% | 798↑1.8% | 784↑5.1% | 746 | |
| Non-Operating Income | 148,851↑16.2% | 128,147↑1423755.6% | 9↑100.1% | -11,168 | 0.00 | |
| Other Income / Expenses | -150,253↓16.2% | -129,332↓15926.3% | -807↓2.9% | -784↓5.1% | -746 | |
| Income Before Tax | 6,710↓15.1% | 7,904↓0.3% | 7,925↑27.0% | 6,238↑4.2% | 5,985 | |
| Income Tax Expense | 1,049↓45.7% | 1,933↑5.6% | 1,830↑9.8% | 1,666↑41.4% | 1,178 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 5,661↓5.2% | 5,971↓2.0% | 6,095↑33.3% | 4,572↓4.9% | 4,807 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 5,661↓5.2% | 5,971↓2.0% | 6,095↑33.3% | 4,572↓4.9% | 4,807 | |
| Bottom-Line Net Income | 5,661↓5.2% | 5,971↓2.0% | 6,095↑33.3% | 4,572↓4.9% | 4,807 | |
| EPS (Basic) | 25.28↓2.1% | 25.81↑3.9% | 24.84↑33.3% | 18.63↓2.0% | 19.01 | |
| EPS (Diluted) | 25.21↓1.8% | 25.68↑7.1% | 23.97↑33.3% | 17.98↓2.7% | 18.47 | |
| Weighted Average Shares | 241↑0.0% | 241↓1.9% | 245↑0.0% | 245↓3.0% | 253 | |
| Weighted Average Diluted Shares | 243↑0.0% | 243↓4.3% | 254↑0.0% | 254↓2.3% | 260 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.